Edition:
India

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

17.55USD
19 Jul 2019
Change (% chg)

$0.04 (+0.23%)
Prev Close
$17.51
Open
$17.55
Day's High
$18.03
Day's Low
$17.55
Volume
73,188
Avg. Vol
52,583
52-wk High
$34.65
52-wk Low
$8.01

About

KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein... (more)

Overall

Beta: --
Market Cap(Mil.): $70.42
Shares Outstanding(Mil.): 9.71
Dividend: --
Yield (%): --

Financials

  KALV.OQ Industry Sector
P/E (TTM): -- 29.88 32.67
EPS (TTM): -3.21 -- --
ROI: -60.80 14.90 14.49
ROE: -61.05 16.02 15.79

Earnings vs. Estimates